DIPG-39. ONCOHISTONE H3. 3K27M-DRIVEN CREB5/ID1 AXIS DICTATES THE MALIGNANT CELL STATES OF DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG)
BACKGROUND Diffuse intrinsic pontine glioma (DIPG) is a highly aggressive pediatric
cancer characterized by the presence of H3K27M-oncohistones, which drive relentless …
cancer characterized by the presence of H3K27M-oncohistones, which drive relentless …
DIPG-50. INSIGHTS INTO TUMORIGENESIS OF DIFFUSE INTRINSIC PONTINE GLIOMA-ONCOHISTONE AND SIGNALING
Y Sun, K Yan, D Wang, W Zhou, Y Wang, C Xu… - Neuro …, 2023 - ncbi.nlm.nih.gov
Diffuse intrinsic pontine glioma (DIPG) is a rare and incurable pediatric brain cancer with
survival of less than one year. Understanding the tumorigenesis mechanisms of DIPG and …
survival of less than one year. Understanding the tumorigenesis mechanisms of DIPG and …
Histone tail analysis reveals H3K36me2 and H4K16ac as epigenetic signatures of diffuse intrinsic pontine glioma
Background Diffuse intrinsic pontine glioma (DIPG) is an aggressive pediatric brainstem
tumor. Most DIPGs harbor a histone H3 mutation, which alters histone post-translational …
tumor. Most DIPGs harbor a histone H3 mutation, which alters histone post-translational …
Dipg-41. Identification of Birc5 as a Novel Therapeutic Target for Diffuse Intrinsic Pontine Glioma
M Li, J Wang, Y Sui, T Li, F Liu, L Zhang, W Jiang… - Neuro …, 2018 - ncbi.nlm.nih.gov
Abstract Diffuse Intrinsic Pontine Glioma (DIPG) remains to be a lethal type of pediatric brain
tumor to date, indicating an urgent need of finding novel therapeutic strategy. Through …
tumor to date, indicating an urgent need of finding novel therapeutic strategy. Through …
DIPG-72. CREATION, CHARACTERIZATION AND CATALOGUING NEXT-GENERATION DIPG PATIENT-DERIVED CANCER CELL LINES: THE DIPG C3 PROJECT
S Bhatia, T Quinn, KH Chow, J Vogelzang… - Neuro …, 2024 - ncbi.nlm.nih.gov
BACKGROUND Preclinical studies of diffuse intrinsic pontine glioma (DIPG) have increased
significantly over the past 15 years due to the development of DIPG disease-specific tools …
significantly over the past 15 years due to the development of DIPG disease-specific tools …
DIPG-29. Genomic landscape of diffuse intrinsic pontine glioma: an analysis of the DIPG-BATs cohort
P Bandopadhayay, NF Greenwald, J Wala… - Neuro …, 2017 - academic.oup.com
INTRODUCTION: Diffuse intrinsic pontine glioma (DIPG) remains a devastating and
incurable disease. The DIPG-BATs clinical trial incorporates diagnostic biopsy with …
incurable disease. The DIPG-BATs clinical trial incorporates diagnostic biopsy with …
DIPG-69. CHARACTERISTICS OF PATIENTS≥ 10 YEARS OF AGE WITH DIFFUSE INTRINSIC PONTINE GLIOMA: A REPORT FROM THE INTERNATIONAL DIPG …
Diffuse intrinsic pontine gliomas (DIPG) are deadly childhood brainstem tumors that
comprise approximately half of all pediatric high-grade gliomas (HGG). Recurrent, clonal …
comprise approximately half of all pediatric high-grade gliomas (HGG). Recurrent, clonal …
DIPG-59. UPREGULATION OF PRENATAL PONTINE ID1 SIGNALING IN DIPG
Abstract Diffuse Intrinsic Pontine Glioma (DIPG) is an incurable pediatric brain tumor.
Current standard of care has shown no improvements in survival. Here, we report our study …
Current standard of care has shown no improvements in survival. Here, we report our study …
DIPG-05. Histone H3. 3 K27M impairs SER31 phosphorylation, resulting in chromosomal instability, loss of cell cycle checkpoint control, and tumor formation
C Day, A Langfald, F Grigore, S Fadness… - Neuro …, 2020 - ncbi.nlm.nih.gov
Diffuse midline gliomas with the H3. 3 K27M mutation are lethal brain tumors in children. H3
K27M causes global loss of Lys27 triple methylation (Lys27me3), inducing epigenetic …
K27M causes global loss of Lys27 triple methylation (Lys27me3), inducing epigenetic …
[HTML][HTML] DIPG-48. DIPG THROUGH THE LOOKING GLASS
SS Senga - Neuro-Oncology, 2023 - researchgate.net
Diffuse intrinsic pontine glioma (DIPG) has a peculiar pathogenesis with canonical Histone
variants H3. 1/H3. 2 wherein Lysine 27 (H3K27) is substituted to methionine (H3K27M). It is …
variants H3. 1/H3. 2 wherein Lysine 27 (H3K27) is substituted to methionine (H3K27M). It is …